• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Circulating level of Angiopoietin-2 is associated with acute kidney injury in coronavirus disease 2019 (COVID-19).

作者信息

Henry Brandon Michael, de Oliveira Maria Helena Santos, Cheruiyot Isaac, Benoit Justin L, Cooper David S, Lippi Giuseppe, Le Cras Timothy D, Benoit Stefanie W

机构信息

The Heart Institute, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH, 45229, USA.

Department of Statistics, Federal University of Parana, Curitiba, Brazil.

出版信息

Angiogenesis. 2021 Aug;24(3):403-406. doi: 10.1007/s10456-021-09782-w. Epub 2021 Mar 23.

DOI:10.1007/s10456-021-09782-w
PMID:33755876
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7985913/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d354/7985913/8dd5a672c2e5/10456_2021_9782_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d354/7985913/8dd5a672c2e5/10456_2021_9782_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d354/7985913/8dd5a672c2e5/10456_2021_9782_Fig1_HTML.jpg

相似文献

1
Circulating level of Angiopoietin-2 is associated with acute kidney injury in coronavirus disease 2019 (COVID-19).血管生成素-2的循环水平与2019冠状病毒病（COVID-19）中的急性肾损伤相关。
Angiogenesis. 2021 Aug;24(3):403-406. doi: 10.1007/s10456-021-09782-w. Epub 2021 Mar 23.
2
Angiopoietin-2 outperforms other endothelial biomarkers associated with severe acute kidney injury in patients with severe sepsis and respiratory failure.血管生成素-2 在预测严重脓毒症和呼吸衰竭患者发生严重急性肾损伤方面优于其他内皮生物标志物。
Crit Care. 2021 Feb 4;25(1):48. doi: 10.1186/s13054-021-03474-z.
3
Platelets and renal failure in the SARS-CoV-2 syndrome.血小板与 SARS-CoV-2 综合征所致肾衰竭。
Platelets. 2021 Jan 2;32(1):130-137. doi: 10.1080/09537104.2020.1817361. Epub 2020 Sep 6.
4
SARS-CoV-2 infection associated acute kidney injury in patients with pre-existing chronic renal disease: A report of two cases.SARS-CoV-2 感染相关的慢性肾脏病患者急性肾损伤：两例报告。
Immun Inflamm Dis. 2020 Dec;8(4):506-511. doi: 10.1002/iid3.333. Epub 2020 Jul 28.
5
Endothelial Dysfunction for Acute Kidney Injury in Coronavirus Disease 2019: How Concerned Should We Be?2019 年冠状病毒病急性肾损伤的血管内皮功能障碍：我们应该有多担心？
Nephron. 2021;145(5):513-517. doi: 10.1159/000515919. Epub 2021 May 27.
6
COVID-19 and AKI: Where Do We Stand?新型冠状病毒肺炎与急性肾损伤：我们目前的情况如何？
J Am Soc Nephrol. 2021 May 3;32(5):1029-1032. doi: 10.1681/ASN.2020121768. Epub 2021 Feb 26.
7
Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients.血管生成素-2 作为内皮细胞激活的标志物，是预测 COVID-19 患者入住重症监护病房的良好预测因子。
Angiogenesis. 2020 Nov;23(4):611-620. doi: 10.1007/s10456-020-09730-0. Epub 2020 May 27.
8
Acute kidney failure in patients admitted due to COVID-19.因 COVID-19 住院的患者中出现急性肾衰竭。
Nefrologia (Engl Ed). 2021 Jan-Feb;41(1):34-40. doi: 10.1016/j.nefro.2020.08.005. Epub 2020 Oct 9.
9
Covid-19 and acute kidney injury.新冠病毒与急性肾损伤。
Am J Hematol. 2021 Jun 1;96(6):747-748. doi: 10.1002/ajh.26089. Epub 2021 Feb 2.
10
Serum Angiopoietin-2 Predicts Mortality and Kidney Outcomes in Decompensated Cirrhosis.血清血管生成素 2 可预测失代偿期肝硬化患者的死亡率和肾脏结局。
Hepatology. 2019 Feb;69(2):729-741. doi: 10.1002/hep.30230. Epub 2019 Jan 4.

引用本文的文献

1
An analysis of novel endothelial biomarkers to ascertain their role as prognostic indicators in severe COVID-19 illness.分析新型内皮生物标志物，以确定它们在重症COVID-19疾病中作为预后指标的作用。
Indian J Med Res. 2025 Mar;161(3):298-305. doi: 10.25259/IJMR_915_2024.
2
Exploring Angiopoietin-2: Clinical Insights and Experimental Perspectives in Kidney Diseases.探索血管生成素-2：肾脏疾病的临床见解与实验展望
Kidney Int Rep. 2024 Sep 6;9(12):3375-3385. doi: 10.1016/j.ekir.2024.09.001. eCollection 2024 Dec.
3
Delineating sex-specific circulating host response signatures associated with COVID-19 severity and mortality.

本文引用的文献

1
Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality.循环血管性血友病因子和高分子量多聚体作为内皮损伤标志物可预测COVID-19患者的院内死亡率。
Angiogenesis. 2021 Aug;24(3):505-517. doi: 10.1007/s10456-020-09762-6. Epub 2021 Jan 15.
2
ADAMTS13 activity to von Willebrand factor antigen ratio predicts acute kidney injury in patients with COVID-19: Evidence of SARS-CoV-2 induced secondary thrombotic microangiopathy.ADAMTS13 活性与血管性血友病因子抗原比值预测 COVID-19 患者的急性肾损伤：SARS-CoV-2 诱导的继发性血栓性微血管病的证据。
Int J Lab Hematol. 2021 Jul;43 Suppl 1(Suppl 1):129-136. doi: 10.1111/ijlh.13415. Epub 2020 Dec 3.
3
描绘与COVID-19严重程度和死亡率相关的性别特异性循环宿主反应特征。
iScience. 2024 Oct 11;27(11):111150. doi: 10.1016/j.isci.2024.111150. eCollection 2024 Nov 15.
4
Angiopoietins as Predictor Indexes in COVID-19 Patients in Delta and Omicron Waves.血管生成素作为德尔塔和奥密克戎毒株流行期新冠患者的预测指标
Curr Issues Mol Biol. 2024 Apr 26;46(5):3975-3989. doi: 10.3390/cimb46050245.
5
NRAS mutation drives elevated angiopoietin-2 expression in human endothelial cells and a genetic mouse model.NRAS 突变驱动人内皮细胞中血管生成素-2 的表达升高，并在遗传小鼠模型中得到验证。
Pediatr Blood Cancer. 2024 Jul;71(7):e31032. doi: 10.1002/pbc.31032. Epub 2024 May 6.
6
The modes of angiogenesis: an updated perspective.血管生成的模式：一个更新的视角。
Angiogenesis. 2023 Nov;26(4):477-480. doi: 10.1007/s10456-023-09895-4. Epub 2023 Aug 28.
7
Pathological angiogenesis: mechanisms and therapeutic strategies.病理性血管生成：机制与治疗策略。
Angiogenesis. 2023 Aug;26(3):313-347. doi: 10.1007/s10456-023-09876-7. Epub 2023 Apr 15.
8
Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies.COVID-19 中的血管内皮功能障碍：证据、生物标志物、机制和潜在治疗方法概述。
Acta Pharmacol Sin. 2023 Apr;44(4):695-709. doi: 10.1038/s41401-022-00998-0. Epub 2022 Oct 17.
9
Programmed cell death lives.程序性细胞死亡重现生机。
Apoptosis. 2022 Oct;27(9-10):619-621. doi: 10.1007/s10495-022-01758-5. Epub 2022 Aug 9.
10
Heparan sulfate mimetic fucoidan restores the endothelial glycocalyx and protects against dysfunction induced by serum of COVID-19 patients in the intensive care unit.硫酸乙酰肝素模拟物岩藻依聚糖可恢复内皮糖萼，并保护免受重症监护病房中COVID-19患者血清诱导的功能障碍。
ERJ Open Res. 2022 May 3;8(2). doi: 10.1183/23120541.00652-2021. eCollection 2022 Apr.
AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19.
新冠肺炎危重症患者急性肾损伤行肾脏替代治疗。
J Am Soc Nephrol. 2021 Jan;32(1):161-176. doi: 10.1681/ASN.2020060897. Epub 2020 Oct 16.
4
Acute Kidney Injury is Associated with Worse Prognosis In COVID-19 Patients: A Systematic Review and Meta-analysis.急性肾损伤与COVID-19患者更差的预后相关：一项系统评价和荟萃分析。
Acta Biomed. 2020 Sep 7;91(3):e2020029. doi: 10.23750/abm.v91i3.10222.
5
SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19.SARS-CoV-2 通过结合血小板 ACE2 来增强 COVID-19 中的血栓形成。
J Hematol Oncol. 2020 Sep 4;13(1):120. doi: 10.1186/s13045-020-00954-7.
6
Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series.华盛顿州致命性 COVID-19 感染的组织病理学和超微结构发现：病例系列研究。
Lancet. 2020 Aug 1;396(10247):320-332. doi: 10.1016/S0140-6736(20)31305-2. Epub 2020 Jul 16.
7
The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection.血管内皮：严重 SARS-CoV-2 感染导致器官功能障碍的基石。
Crit Care. 2020 Jun 16;24(1):353. doi: 10.1186/s13054-020-03062-7.
8
Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients.血管生成素-2 作为内皮细胞激活的标志物，是预测 COVID-19 患者入住重症监护病房的良好预测因子。
Angiogenesis. 2020 Nov;23(4):611-620. doi: 10.1007/s10456-020-09730-0. Epub 2020 May 27.
9
Endothelial cell infection and endotheliitis in COVID-19.新型冠状病毒肺炎中的内皮细胞感染与内皮炎
Lancet. 2020 May 2;395(10234):1417-1418. doi: 10.1016/S0140-6736(20)30937-5. Epub 2020 Apr 21.
10
Angiopoietin-2 as a predictor of acute kidney injury in critically ill patients and association with ARDS.血管生成素-2 作为危重症患者急性肾损伤的预测因子，与 ARDS 相关。
Respirology. 2019 Apr;24(4):345-351. doi: 10.1111/resp.13464. Epub 2019 Jan 17.